CD177 and cancer: suggested that more aggressive cancer cells exhibit an elevated capability to uptake NPs.[46] Additionally, M2‐like TAMs may facilitate NP uptake by cancer cells via phagocytosis or by altering the expression of cell surface receptors or transporters on cancer cells, thereby creating a conducive environment for NP uptake.